Drug Reimbursement in Canada

Posted 01 September 2017 By George Wyatt, MBA

placeholder+image This article provides a high-level overview of the elements of prescription drug reimbursement in Canada and discusses the costs, processes and reimbursement plans associated with a number of federal health agencies and payers and describes some of the variety of drug plans in place.

Share this article:

Categories: Biologics and biotechnology, Drugs, Reimbursement, Features, Canada, Health Canada

Tags: Reimbursement, Coverage, Health Technology Assessment, HTA, Common Drug Review

Regulatory Exchange: Latest Updates From the Community